Mingming Pan

Title: Innovations of Mingming Pan in Antibody Development

Introduction

Mingming Pan is a notable inventor based in Shanghai, China, recognized for his contributions to the field of biotechnology. He holds two patents that focus on innovative antibody development aimed at combating tumors and treating autoimmune diseases. His work has significant implications for cancer therapy and immune system modulation.

Latest Patents

Mingming Pan's latest patents include the "SEMA4D antibody, preparation method therefor and use thereof." This invention provides a murine or fully human monoclonal antibody that targets SEMA4D, binding to the SEMA4D antigen and exhibiting activities that combat tumors. Another significant patent is the "4-1BB antibody and preparation method and use thereof." This invention features a 4-1BB antibody with high affinity to the 4-1BB protein, effectively activating downstream signaling and significantly increasing the expression of IFN-γ and IL-2 in human mixed lymphocytes or T lymphocytes. This antibody has potential applications in treating cancers and autoimmune diseases.

Career Highlights

Mingming Pan has worked with prominent companies in the pharmaceutical and biotechnology sectors, including Jiangsu Huaiyu Pharmaceutical Co., Ltd. and Shanghai Hyamab Biotech Co., Ltd. His experience in these organizations has contributed to his expertise in antibody research and development.

Collaborations

Mingming Pan has collaborated with notable professionals in his field, including Shaoping Hu and Lile Liu. These collaborations have likely enhanced his research capabilities and broadened the impact of his inventions.

Conclusion

Mingming Pan's innovative work in antibody development showcases his significant contributions to biotechnology. His patents reflect a commitment to advancing cancer treatment and improving immune responses. His collaborations and career experiences further underscore his role as a leading inventor in this vital field.